NovaBay Pharmaceuticals's activity chart (see below) currently has 18 price targets and 14 ratings on display.
Analysts' price targets on this stock were met 20.83% of the time, taking 78.25 days on average.
Most recent stock forecast was given by EDWARD WOO from ASCENDIANT on 11-Nov-2024. First documented stock forecast 06-Feb-2017.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 16-Nov-2018
$0.85
2 years 11 days ago
(11-Nov-2024)
0/5 (0%)
$-1.5 (-63.83%)
Buy Since 18-Sep-2019
$13475
2 years 6 months 9 days ago
(13-May-2024)
0/3 (0%)
$11167.22 (483.89%)
Buy Since 06-Feb-2017
$7656.27
$24500
7 years 8 months 9 days ago
(13-Mar-2019)
1/3 (33.33%)
$2109.51 (38.03%)
89
Buy Since 05-Jun-2017
$4900
$33687.57
8 years 7 months 27 days ago
(26-Mar-2018)
1/2 (50%)
$-9472.99 (-65.91%)
224
What is NBY (NovaBay Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on NBY (NovaBay Pharmaceuticals)?
Which analyst has the lowest performance score on NBY (NovaBay Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on NBY (NovaBay Pharmaceuticals)?
Which analyst is the currently most bullish on NBY (NovaBay Pharmaceuticals)?
Which analyst is the currently most reserved on NBY (NovaBay Pharmaceuticals)?